Published online Oct 26, 2020. doi: 10.4330/wjc.v12.i10.484
Peer-review started: March 19, 2020
First decision: July 5, 2020
Revised: July 19, 2020
Accepted: August 15, 2020
Article in press: August 15, 2020
Published online: October 26, 2020
Processing time: 218 Days and 4.9 Hours
There is risk of stenosis and thrombosis of the superior vena cava after upper extremity central catheter replacement. This complication is more serious among patients with single ventricle physiology, as it might preclude them from undergoing further life-sustaining palliative surgery. Data on the rate of venous thrombosis in children with single ventricle physiology with upper extremity central venous catheters are limited. Also, there is a wide variation in practice regarding the choice of central access in this population across the centers.
To study the risk of using upper body percutaneously inserted central catheter (PICC) in single ventricle patients. The results of this study could be used to develop a multicenter study to determine the risk and benefit of using this type and location of the catheter in this population.
To describe the incidence of thrombosis associated with the use of PICCs in patients with single ventricle physiology.
We retrospectively reviewed the charts of patients with single ventricle physiology who underwent second stage palliation surgery. Data regarding the type and duration of central venous access were collected in addition to the data regarding thrombosis or stenosis.
We reviewed a total of seventy-six patients underwent superior cavopulmonary anastomoses, of which 56 (73%) had an upper extremity PICC at some point prior to this procedure. Median duration of PICC usage was 24 d (25%, 75%: 12, 39). Seventeen patients (30%) with PICCs also had internal jugular or subclavian central venous catheters (CVCs) in place at some point prior to their superior cavopulmonary anastomoses with a median duration of 10 days (25%, 75%: 8, 14). Thrombus was detected in association with 2 of the 56 PICCs (4%) and 3 of the 17 CVCs (18%) and the incidence of thrombosis was significantly different between the PICCs vs CVCs (P < 0.04). All five patients were placed on therapeutic dose of low molecular weight heparin at the time of thrombus detection and subsequent cardiac catheterization demonstrated resolution in three of the five patients. No patients developed clinically significant venous stenosis.
The placement of PICC in the upper extremity in children with single ventricle physiology was associated with low risk of clinically significant stenosis or thrombosis and provide a reliable way to have long-lasting central venous access.
Further research and multicenter studies specifically looking at the incidence of complications with upper body PICCs in single ventricle patients are warranted.